Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
Posted September 1, 2022
Cross-posted from hivinfo.nih.gov
The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the following section of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Highlights from the section are summarized below:
- The Panel updated the Drug–Drug Interactions tables (Tables 24a–f) with guidance on the interaction potentials between antiretroviral drugs and antiviral drugs (brincidofovir, cidofovir, or tecovirimat) that are currently being used to treat monkeypox.
For a complete list of updates, please see What’s New in the Guidelines. To view or download the guidelines, please see the Adult and Adolescent ARV Guidelines section of Clinical Info’s website. The guidelines tables and recommendations can also be downloaded as separate PDF files.
Clinical Info welcomes your feedback on the latest revisions to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Please send your comments with the subject line “Adult and Adolescent ARV Guidelines” to HIVinfo@NIH.gov by September 22, 2022.
